A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer ; volume:15 ; number:3 ; day:20 ; month:6 ; year:2013 ; pages:1-11 ; date:6.2013
Breast cancer research ; 15, Heft 3 (20.6.2013), 1-11, 6.2013
- Urheber
-
Serrano, Davide
- Beteiligte Personen und Organisationen
-
Lazzeroni, Matteo
Gandini, Sara
Macis, Debora
Johansson, Harriet
Gjerde, Jennifer
Lien, Ernst
Feroce, Irene
Pruneri, Giancarlo
Sandri, Maria Teresa
Bassi, Fabio
Brenelli, Fabricio
Luini, Alberto
Cazzaniga, Massimiliano
Varricchio, Clara
Guerrieri-Gonzaga, Aliana
Decensi, Andrea
Bonanni, Bernardo
SpringerLink (Online service)
- DOI
-
10.1186/bcr3439
- URN
-
urn:nbn:de:1111-2016032417685
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Serrano, Davide
- Lazzeroni, Matteo
- Gandini, Sara
- Macis, Debora
- Johansson, Harriet
- Gjerde, Jennifer
- Lien, Ernst
- Feroce, Irene
- Pruneri, Giancarlo
- Sandri, Maria Teresa
- Bassi, Fabio
- Brenelli, Fabricio
- Luini, Alberto
- Cazzaniga, Massimiliano
- Varricchio, Clara
- Guerrieri-Gonzaga, Aliana
- Decensi, Andrea
- Bonanni, Bernardo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
A retrospective cohort study of tamoxifen versus surgical treatment for ER-positive gynecomastia
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen
Assessing vaginal wall indexes in premenopausal versus postmenopausal women by transrectal linear array high-frequency probe
Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer
Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer
Gene products of chromosome 11q and their association with CCND1gene amplification and tamoxifen resistance in premenopausal breast cancer
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
A retrospective cohort study of tamoxifen versus surgical treatment for ER-positive gynecomastia
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen
Assessing vaginal wall indexes in premenopausal versus postmenopausal women by transrectal linear array high-frequency probe
Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer
Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer
Gene products of chromosome 11q and their association with CCND1gene amplification and tamoxifen resistance in premenopausal breast cancer
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
A retrospective cohort study of tamoxifen versus surgical treatment for ER-positive gynecomastia
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen
Assessing vaginal wall indexes in premenopausal versus postmenopausal women by transrectal linear array high-frequency probe
Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer
Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer
Gene products of chromosome 11q and their association with CCND1gene amplification and tamoxifen resistance in premenopausal breast cancer